H. S. sought to patent a novel method of synthesizing a specific protein using a genetically modified organism. The method involved both naturally occurring substances and human-made components. The U.S. Patent and Trademark Office (PTO) initially rejected the application on the grounds that the method did not sufficiently transform the natural product into something patentable. H. S. appealed to the United States Court of Appeals for the Federal Circuit, arguing that the process involved a significant amount of human intervention, thus qualifying for patent protection under current laws.
Does the use of naturally occurring proteins in a biotechnological process, when significantly altered by human intervention, qualify as patentable subject matter under current patent law?
Under 35 U.S.C. § 101, patentable subject matter includes any new and useful process, machine, manufacture, or composition of matter. However, laws of nature, natural phenomena, and abstract ideas are not patentable. The court applies the Alice/Mayo framework to determine patent eligibility, focusing on whether the claimed process amounts to significantly more than a patent on the ineligible concept itself.
The court reversed the PTO's decision, holding that the method described by H. S. constitutes patentable subject matter. The court found that the procedure involved an inventive application of natural principles, thus meeting the requirements for patent eligibility.
The court applied the two-step Alice/Mayo test. First, it assessed whether the claims were directed to a patent-ineligible concept. Although the process involved naturally occurring proteins, the court moved to the second step, determining whether the claims involved an 'inventive concept' sufficient to transform the nature of the claim into a patent-eligible application. The court found significant human intervention in synthesizing the protein, which constitutes an inventive application, thus qualifying the method for patent protection under § 101. The court emphasized the importance of recognizing human ingenuity and the transformative steps required to achieve the claimed result.
This case is significant for law students and practitioners because it clarifies the application of the Alice/Mayo test in the biosciences. The decision underscores how biotechnological innovations, even when utilizing natural phenomena, can qualify for protection if they exhibit significant human-engineered modifications. It presents an important precedent for determining the limits of patent eligibility in a field where the line between natural and human-made inventions often blurs.
In re Application of H. S. serves as a landmark decision in the field of biotechnology patent law. The case exemplifies how courts navigate the challenge of applying established legal tests to advanced, technological innovations. By affirming the patent eligibility of biotechnological processes that significantly transform natural phenomena, this ruling not only supports technological progress but also provides a foundation for future legal interpretations. The court's application of the Alice/Mayo framework to the biotechnological context demonstrates the judicial system’s capacity to adapt to new technologies while ensuring that the principles of patent law are consistently applied. For law students, this case is an essential study in understanding the nuances of patent law as it applies to one of the most innovative sectors, preparing them to analyze similar issues in their legal careers.